Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4333)
All Articles published online
|
Jan 7, 2009 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahmadi A, Polyak S, Draganov PV. Colorectal cancer surveillance in inflammatory bowel disease: The search continues. World J Gastroenterol 2009; 15(1): 61-66 [PMID: 19115469 DOI: 10.3748/wjg.15.61] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i1/61.htm |
| Number | Citing Articles |
| 1 |
Kathryn E Hamilton, P Kay Lund, Joseph A Galanko, Robert S Sandler, Temitope O Keku. Suppressor of cytokine signaling 3 (SOCS3) is not an independent biomarker of colorectal adenoma risk. BMC Research Notes 2010; 3(1) doi: 10.1186/1756-0500-3-144
|
| 2 |
|
| 3 |
Emilie Viennois, Sarah A. Ingersoll, Saravanan Ayyadurai, Yuan Zhao, Lixin Wang, Mingzhen Zhang, Moon K. Han, Pallavi Garg, Bo Xiao, Didier Merlin. Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model. Cellular and Molecular Gastroenterology and Hepatology 2016; 2(3): 340 doi: 10.1016/j.jcmgh.2016.01.006
|
| 4 |
O.V. Arkhipova. Detection of colonic dysplasia in patients with ulcerative colitis. Dokazatel'naya gastroenterologiya 2020; 9(1): 68 doi: 10.17116/dokgastro2020901168
|
| 5 |
Emilie Viennois, Benoit Chassaing. Consumption of Select Dietary Emulsifiers Exacerbates the Development of Spontaneous Intestinal Adenoma. International Journal of Molecular Sciences 2021; 22(5): 2602 doi: 10.3390/ijms22052602
|
| 6 |
J. Rafael Montenegro-Burke, Bernard P. Kok, Carlos Guijas, Xavier Domingo-Almenara, Clara Moon, Andrea Galmozzi, Seiya Kitamura, Lars Eckmann, Enrique Saez, Gary E. Siuzdak, Dennis W. Wolan. Metabolomics activity screening of T cell–induced colitis reveals anti-inflammatory metabolites. Science Signaling 2021; 14(702) doi: 10.1126/scisignal.abf6584
|
| 7 |
Sepehr Edalatkhah, Ebrahim Hazrati, Mahmoodreza Hashemi, Alireza Golaghaei, Behroz Kheradmand, Mohamadreza Rafiei. Evaluation of anesthesia quality with three methods: “propofol + fentanyl” vs. “propofol + fentanyl + lidocaine” vs. “propofol + fentanyl + lidocaine + ketamine” in patients referred to the scoping ward. Journal of Family Medicine and Primary Care 2022; 11(2): 672 doi: 10.4103/jfmpc.jfmpc_1387_21
|
| 8 |
Olivier Boulard, Stefanie Kirchberger, Daniel J. Royston, Kevin J. Maloy, Fiona M. Powrie. Identification of a genetic locus controlling bacteria-driven colitis and associated cancer through effects on innate inflammation. Journal of Experimental Medicine 2012; 209(7): 1309 doi: 10.1084/jem.20120239
|
| 9 |
Jose Francisco Nunes Pereira das Neves, Mariana Moraes Pereira das Neves Araújo, Fernando de Paiva Araújo, Clarice Martins Ferreira, Fabiana Baeta Neves Duarte, Fabio Heleno Pace, Laura Cotta Ornellas, Todd H. Baron. Colonoscopy sedation: clinical trial comparing propofol and fentanyl with or without midazolam. Brazilian Journal of Anesthesiology (English Edition) 2016; 66(3): 231 doi: 10.1016/j.bjane.2014.09.014
|
| 10 |
María Chaparro, María Trapero-Marugán, Mercedes Guijarro, Consuelo López, Ricardo Moreno-Otero, Javier P. Gisbert. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: A case report and a short review of the literature. Journal of Crohn's and Colitis 2013; 7(2): e61 doi: 10.1016/j.crohns.2012.04.005
|
| 11 |
Hajir Ibraheim, Angad Singh Dhillon, Ioannis Koumoutsos, Shraddha Gulati, Bu’Hussain Hayee. Curriculum review: colorectal cancer surveillance and management of dysplasia in IBD. Frontline Gastroenterology 2018; 9(4): 271 doi: 10.1136/flgastro-2017-100919
|
| 12 |
Fabio Mastrogiovanni, Anindya Mukhopadhya, Nicola Lacetera, Marion Ryan, Annalisa Romani, Roberta Bernini, Torres Sweeney. Anti-Inflammatory Effects of Pomegranate Peel Extracts on In Vitro Human Intestinal Caco-2 Cells and Ex Vivo Porcine Colonic Tissue Explants. Nutrients 2019; 11(3): 548 doi: 10.3390/nu11030548
|
| 13 |
Yoshitaka Ueno, Shinji Tanaka, Kazuaki Chayama. Non-Polypoid Colorectal Neoplasms in Ulcerative Colitis. Gastrointestinal Endoscopy Clinics of North America 2010; 20(3): 525 doi: 10.1016/j.giec.2010.04.002
|
| 14 |
D. Hock, R. Materne, R. Ouhadi, I. Mancini, A. Nchimi. Colonoscopie virtuelle par scanner. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2011; 6(1): 1 doi: 10.1016/S1879-8527(11)72857-X
|
| 15 |
Rupert W.L. Leong, Jonathan Perry, Brayden Campbell, Jenn Koo, Ian B. Turner, Crispin Corte, Ian K. Fok. Knowledge and predictors of dysplasia surveillance performance in inflammatory bowel diseases in Australia. Gastrointestinal Endoscopy 2015; 82(4): 708 doi: 10.1016/j.gie.2015.04.004
|
| 16 |
Aikaterini Mastoraki, Constantinos Safioleas, George Sakorafas, Michael Safioleas. Cecum Adenocarcinoma as the First Manifestation of Crohn's Disease in a 24-Year-Old Woman: Dilemmas in Differential Diagnosis and Management. The American Surgeon 2010; 76(4): 5 doi: 10.1177/000313481007600403
|
| 17 |
Jong-Min Park, Na Young Han, Young-Min Han, Mi Kyung Chung, Hoo Keun Lee, Kwang Hyun Ko, Eun-Hee Kim, Ki Baik Hahm. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: Where are we now in the era of the next generation proteomics?. World Journal of Gastroenterology 2014; 20(37): 13466-13476 doi: 10.3748/wjg.v20.i37.13466
|
| 18 |
Cinzia Papadia, Joost Louwagie, Paolo Del Rio, Madeleine Grooteclaes, Alessandro Coruzzi, Chiara Montana, Marco Novelli, Cesare Bordi, Gian Luigi de’ Angelis, Paul Bassett, Joseph Bigley, Bryan Warren, Wendy Atkin, Alastair Forbes. FOXE1 and SYNE1 Genes Hypermethylation Panel as Promising Biomarker in Colitis-associated Colorectal Neoplasia. Inflammatory Bowel Diseases 2014; 20(2): 271 doi: 10.1097/01.MIB.0000435443.07237.ed
|
| 19 |
Emilie Viennois, Didier Merlin, Andrew T. Gewirtz, Benoit Chassaing. Dietary Emulsifier–Induced Low-Grade Inflammation Promotes Colon Carcinogenesis. Cancer Research 2017; 77(1): 27 doi: 10.1158/0008-5472.CAN-16-1359
|
| 20 |
Jing Xiong, Ying-Hao Lin, Li-Hong Bi, Ji-De Wang, Yang Bai, Si-De Liu. Effects of Interleukin-4 or Interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-165
|
| 21 |
|
| 22 |
Angelo Pietro Femia, Alexander Swidsinski, Piero Dolara, Maddalena Salvadori, Amedeo Amedei, Giovanna Caderni, Yohannes Tesfaigzi. Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration. PLoS ONE 2012; 7(1): e29918 doi: 10.1371/journal.pone.0029918
|
| 23 |
Junko Kishikawa, Kazushige Kawai, Nelson H. Tsuno, Soichiro Ishihara, Hironori Yamaguchi, Eiji Sunami, Toshiaki Watanabe. Characteristics and Prognosis of Colorectal Cancer Associated With Rheumatic Disease. International Surgery 2015; 100(5): 783 doi: 10.9738/INTSURG-D-14-00154.1
|
| 24 |
J.-P. Ritz, H. J. Buhr. Praxis der Viszeralchirurgie Onkologische Chirurgie. 2010; : 693 doi: 10.1007/978-3-642-03808-2_47
|
| 25 |
Pnina Brodt. Metastasis of Colorectal Cancer. Cancer Metastasis - Biology and Treatment 2010; 14: 289 doi: 10.1007/978-90-481-8833-8_10
|
| 26 |
Matthew Barnett, Emma Bermingham, Warren McNabb, Shalome Bassett, Kelly Armstrong, John Rounce, Nicole Roy. Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2010; 690(1-2): 71 doi: 10.1016/j.mrfmmm.2010.02.006
|
| 27 |
T. Banasiewicz, R. Marciniak, J. Paszkowski, P. Krokowicz, E. Kaczmarek, J. Walkowiak, J. Szmeja, P. Majewski, M. Drews. Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis.. Colorectal Disease 2012; 14(1): 92 doi: 10.1111/j.1463-1318.2011.02547.x
|
| 28 |
B. Pardini, A. Naccarati, P. Vodicka, R. Kumar. Gene expression variations: potentialities of master regulator polymorphisms in colorectal cancer risk. Mutagenesis 2012; 27(2): 161 doi: 10.1093/mutage/ger057
|
| 29 |
Matthias Barral, Anthony Dohan, Matthieu Allez, Mourad Boudiaf, Marine Camus, Valérie Laurent, Christine Hoeffel, Philippe Soyer. Gastrointestinal cancers in inflammatory bowel disease: An update with emphasis on imaging findings. Critical Reviews in Oncology/Hematology 2016; 97: 30 doi: 10.1016/j.critrevonc.2015.08.005
|
| 30 |
Jin-Kyung Kim, Eun Kyung Shin, Jun Hong Park, Yoon Hee Kim, Jung Han Yoon Park. Antitumor and antimetastatic effects of licochalcone A in mouse models. Journal of Molecular Medicine 2010; 88(8): 829 doi: 10.1007/s00109-010-0625-2
|
| 31 |
Amosy E. M’Koma, Harold L. Moses, Samuel E. Adunyah. Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. International Journal of Colorectal Disease 2011; 26(5): 533 doi: 10.1007/s00384-011-1137-4
|
| 32 |
Bishnu P. Joshi, Zhongyao Liu, Sakib F. Elahi, Henry D. Appelman, Thomas D. Wang. Near-infrared-labeled peptide multimer functions as phage mimic for high affinity, specific targeting of colonic adenomas in vivo (with videos). Gastrointestinal Endoscopy 2012; 76(6): 1197 doi: 10.1016/j.gie.2012.07.017
|
| 33 |
A. Dohan, S.A. Faraoun, M. Barral, Y. Guerrache, M. Boudiaf, X. Dray, C. Hoeffel, M. Allez, O. Farges, L. Beaugerie, T. Aparicio, P. Marteau, E.K. Fishman, O. Lucidarme, C. Eveno, M. Pocard, R. Dautry, P. Soyer. Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. Diagnostic and Interventional Imaging 2015; 96(9): 871 doi: 10.1016/j.diii.2015.02.009
|
| 34 |
Maurizio Martini, Anna Maria Ferrara, Manuela Giachelia, Emiliano Panieri, Katherine Siminovitch, Tommaso Galeotti, Luigi Maria Larocca, Giovambattista Pani. Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients. Inflammatory Bowel Diseases 2012; 18(3): 439 doi: 10.1002/ibd.21814
|
| 35 |
Monique M. Gerrits, Min Chen, Myrte Theeuwes, Herman van Dekken, Marjolein Sikkema, Ewout W. Steyerberg, Hester F. Lingsma, Peter D. Siersema, Bing Xia, Johannes G. Kusters, C. Janneke van der Woude, Ernst J. Kuipers. Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case–control study. Cellular Oncology 2011; 34(2): 107 doi: 10.1007/s13402-010-0006-4
|
| 36 |
|
| 37 |
Athanasios P. Desalermos, Francis A. Farraye, Hannah L. Miller. Nutritional Management of Inflammatory Bowel Diseases. 2016; : 31 doi: 10.1007/978-3-319-26890-3_3
|
| 38 |
Pnina Brodt. Surviving host innate immunity. OncoImmunology 2012; 1(9): 1601 doi: 10.4161/onci.21424
|
| 39 |
G. Murillo, V. Nagpal, N. Tiwari, R.V. Benya, R.G. Mehta. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. The Journal of Steroid Biochemistry and Molecular Biology 2010; 121(1-2): 403 doi: 10.1016/j.jsbmb.2010.03.009
|
| 40 |
Carmine Stolfi, Francesco Pallone, Giovanni Monteleone. Colorectal Cancer Chemoprevention by Mesalazine and Its Derivatives. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/980458
|
| 41 |
Elisa Cattaneo, Michael Baudis, Federico Buffoli, Maria Antonia Bianco, Fausto Zorzi, Giancarlo Marra. Pre-Invasive Disease: Pathogenesis and Clinical Management. 2011; : 369 doi: 10.1007/978-1-4419-6694-0_18
|
| 42 |
Ibrahim Altamemi, E. Angela Murphy, James F. Catroppo, Elizabeth E. Zumbrun, Jiajia Zhang, Jamie L. McClellan, Udai P. Singh, Prakash S. Nagarkatti, Mitzi Nagarkatti. Role of microRNAs in Resveratrol-Mediated Mitigation of Colitis-Associated Tumorigenesis inApcMin/+Mice. Journal of Pharmacology and Experimental Therapeutics 2014; 350(1): 99 doi: 10.1124/jpet.114.213306
|
| 43 |
Zane R Gallinger, Adam V Weizman. Colorectal cancer in inflammatory bowel disease: a shift in risk?. Expert Review of Anticancer Therapy 2014; 14(7): 847 doi: 10.1586/14737140.2014.895936
|
| 44 |
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancer. Journal of Coloproctology 2017; 37(01): 055 doi: 10.1016/j.jcol.2016.06.005
|
| 45 |
Jose Francisco Nunes Pereira das Neves, Mariana Moraes Pereira das Neves Araújo, Fernando de Paiva Araújo, Clarice Martins Ferreira, Fabiana Baeta Neves Duarte, Fabio Heleno Pace, Laura Cotta Ornellas, Todd H. Baron. Sedação para colonoscopia: ensaio clínico comparando propofol e fentanil associado ou não ao midazolam. Brazilian Journal of Anesthesiology 2016; 66(3): 231 doi: 10.1016/j.bjan.2014.09.004
|
| 46 |
Claudia Mescoli, Laura Albertoni, Renata D’incá, Massimo Rugge. Dysplasia in inflammatory bowel diseases. Digestive and Liver Disease 2013; 45(3): 186 doi: 10.1016/j.dld.2012.07.013
|
| 47 |
Lora Hristova, Philippe Soyer, Christine Hoeffel, Philippe Marteau, Abderrahim Oussalah, Anne Lavergne-Slove, Mourad Boudiaf, Anthony Dohan, Valérie Laurent. Colorectal cancer in inflammatory bowel diseases: CT features with pathological correlation. Abdominal Imaging 2013; 38(3): 421 doi: 10.1007/s00261-012-9947-6
|
| 48 |
Christel Rousseaux, Noura El-Jamal, Mathurin Fumery, Caroline Dubuquoy, Olivier Romano, Denis Chatelain, Audrey Langlois, Benjamin Bertin, David Buob, Jean Frederic Colombel, Antoine Cortot, Pierre Desreumaux, Laurent Dubuquoy. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ. Carcinogenesis 2013; 34(11): 2580 doi: 10.1093/carcin/bgt245
|
| 49 |
O. Fogel, C. Richard-Miceli, J. Tost. Chromatin Remodelling and Immunity. Advances in Protein Chemistry and Structural Biology 2017; 106: 139 doi: 10.1016/bs.apcsb.2016.09.003
|
| 50 |
Muhammad Shahid Nadeem, Vikas Kumar, Fahad A. Al-Abbasi, Mohammad Amjad Kamal, Firoz Anwar. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020; 64: 51 doi: 10.1016/j.semcancer.2019.05.001
|